Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengting Yu

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Plos One|December 21, 2023
Distribution pattern, molecular transmission networks, and phylodynamic of hepatitis C virus in ChinaJingrong Ye, Yanming Sun, Jia Li, et al.
Nature|April 17, 2024
Brain endothelial GSDMD activation mediates inflammatory BBB breakdownChao Wei, Wei Jiang, Ruiyu Wang, et al.
Open Forum Infectious Diseases|October 19, 2020
The Yield and Consistency of the Detection of SARS-CoV-2 in Multiple Respiratory SpecimensHaixia Zhang, Meiling Chen, Yanhua Zhang, et al.
Annals of Internal Medicine|April 1, 2020
SARS-CoV-2-Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19Chen Chen, Guiju Gao, Yanli Xu, et al.
Immunity|June 24, 2021
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional speciesRuoke Wang, Qi Zhang, Jiwan Ge, et al.
National Science Review|October 22, 2021
COVID-19 reinfection in the presence of neutralizing antibodiesJu Zhang, Nan Ding, Lili Ren, et al.
The Lancet Regional Health. Western Pacific|August 7, 2023
Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96Bin Su, Guiju Gao, Min Wang, et al.
Nature Communications|October 31, 2020
Genomic surveillance of COVID-19 cases in BeijingPengcheng Du, Nan Ding, Jiarui Li, et al.
Science China. Life Sciences|June 4, 2021
Distinct durability of IgM/IgG antibody responses in COVID-19 patients with differing severityJunyan Han, Ning Zhang, Danying Chen, et al.
Cell Reports|January 4, 2022
Two-step fitness selection for intra-host variations in SARS-CoV-2Jiarui Li, Pengcheng Du, Lijiang Yang, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Plos One|December 21, 2023
Distribution pattern, molecular transmission networks, and phylodynamic of hepatitis C virus in ChinaJingrong Ye, Yanming Sun, Jia Li, et al.
Nature|April 17, 2024
Brain endothelial GSDMD activation mediates inflammatory BBB breakdownChao Wei, Wei Jiang, Ruiyu Wang, et al.
Open Forum Infectious Diseases|October 19, 2020
The Yield and Consistency of the Detection of SARS-CoV-2 in Multiple Respiratory SpecimensHaixia Zhang, Meiling Chen, Yanhua Zhang, et al.
Annals of Internal Medicine|April 1, 2020
SARS-CoV-2-Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19Chen Chen, Guiju Gao, Yanli Xu, et al.
Immunity|June 24, 2021
Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional speciesRuoke Wang, Qi Zhang, Jiwan Ge, et al.
National Science Review|October 22, 2021
COVID-19 reinfection in the presence of neutralizing antibodiesJu Zhang, Nan Ding, Lili Ren, et al.
The Lancet Regional Health. Western Pacific|August 7, 2023
Efficacy and safety of ainuovirine versus efavirenz combination therapies with lamivudine/tenofovir disoproxil fumarate for medication of treatment-naïve HIV-1-positive adults: week 48 results of a randomized controlled phase 3 clinical trial followed by an open-label setting until week 96Bin Su, Guiju Gao, Min Wang, et al.
Nature Communications|October 31, 2020
Genomic surveillance of COVID-19 cases in BeijingPengcheng Du, Nan Ding, Jiarui Li, et al.
Science China. Life Sciences|June 4, 2021
Distinct durability of IgM/IgG antibody responses in COVID-19 patients with differing severityJunyan Han, Ning Zhang, Danying Chen, et al.
Cell Reports|January 4, 2022
Two-step fitness selection for intra-host variations in SARS-CoV-2Jiarui Li, Pengcheng Du, Lijiang Yang, et al.
Pageof 6